Related party transactions |
| Additional disclosure of related party transactions - applicable only in case the related party transaction relates to loans, inter-corporate deposits, advances or investments made or given by the listed entity/subsidiary. These details need to be disclosed only once, during the reporting period when such transaction was undertaken. |
Sr No. | Details of the party (listed entity /subsidiary) entering into the transaction | Details of the counterparty | Type of related party transaction | Details of other related party transaction | Value of the related party transaction as approved by the audit committee | Remarks on approval by audit committee | Value of transaction during the reporting period | In case monies are due to either party as a result of the transaction | In case any financial indebtedness is incurred to make or give loans, inter-corporate deposits, advances or investments | Details of the loans, inter-corporate deposits, advances or investments | Notes |
Name | PAN | Name | PAN | Relationship of the counterparty with the listed entity or its subsidiary | Opening balance | Closing balance | Nature of indebtedness (loan/ issuance of debt/ any other etc.) | Details of other indebtedness | Cost | Tenure | Nature (loan/ advance/ intercorporate deposit/ investment ) | Interest Rate (%) | Tenure | Secured/ unsecured | Purpose for which the funds will be utilised by the ultimate recipient of funds (endusage) |
1 | Rossari Biotech Limited | | Sunil Chari | | Key Managerial Personnel | Remuneration | | | As per the Companies Act, 2013 and Shareholders' Approval | 7 | 0 | 0 | | | | | | | | | | Textual Information(1) |
2 | Rossari Biotech Limited | | Edward Menezes | | Key Managerial Personnel | Remuneration | | | As per the Companies Act, 2013 and Shareholders' Approval | 6.96 | 0 | 0 | | | | | | | | | | Textual Information(2) |
3 | Rossari Biotech Limited | | Mikhail Menezes | | Relative of Directors | Remuneration | | | As per the Companies Act, 2013 and Shareholders' Approval | 4.13 | 0 | 0 | | | | | | | | | | Textual Information(3) |
4 | Rossari Biotech Limited | | Yash Chari | | Relative of Directors | Remuneration | | | As per the Companies Act, 2013 and Shareholders' Approval | 4.14 | 0 | 0 | | | | | | | | | | Textual Information(4) |
5 | Rossari Biotech Limited | | Ketan Sablok | | Key Managerial Personnel | Remuneration | | | NA | 11.67 | 0 | 0 | | | | | | | | | | Textual Information(5) |
6 | Rossari Biotech Limited | | Parul Gupta | | Key Managerial Personnel | Remuneration | | | NA | 1.53 | 0 | 0 | | | | | | | | | | Textual Information(6) |
7 | Rossari Biotech Limited | | Aseem Dhru | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.5 | 0 | 0 | | | | | | | | | | Textual Information(7) |
8 | Rossari Biotech Limited | | Sharabh Pachory | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.9 | 0 | 0 | | | | | | | | | | Textual Information(8) |
9 | Rossari Biotech Limited | | Aparna Sharma | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.9 | 0 | 0 | | | | | | | | | | Textual Information(9) |
10 | Rossari Biotech Limited | | Esha Achan | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.8 | 0 | 0 | | | | | | | | | | Textual Information(10) |
11 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Sale of goods or services | | 750 | NA | 124.24 | 255.47 | 380.82 | | | | | | | | | | Textual Information(11) |
12 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Purchase of goods or services | | 30 | NA | 0.26 | 0 | 0 | | | | | | | | | | Textual Information(12) |
13 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Interest received | | 250 | The Audit Committee has approved an aggregate limit of Rs.250 million | 9.73 | 0 | 0 | | | | | | | | | | Textual Information(13) |
14 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Loan | | 250 | The Audit Committee has approved an aggregate limit of Rs.250 million | 0 | 240.3 | 240 | | | | | Loan | 0.08 | On Demand | Unsecured | General Business Requirement | Textual Information(14) |
15 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Any other transaction | Employee Cost - Recovery | 30 | The Audit Committee has approved an aggregate limit of Rs.30 million | 4.84 | 0 | 0 | | | | | | | | | | Textual Information(15) |
16 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Any other transaction | Employee Cost - Reimbursement | 30 | The Audit Committee has approved an aggregate limit of Rs.30 million | 0.91 | 0 | 0 | | | | | | | | | | Textual Information(16) |
17 | Rossari Biotech Limited | | Buzil Rossari Private Limited | | Wholly Owned Subsidiary Company | Any other transaction | Recovery of Expenses | 30 | The Audit Committee has approved an aggregate limit of Rs.30 million | 3.7 | 0 | 0 | | | | | | | | | | Textual Information(17) |
18 | Rossari Biotech Limited | | Rossari Consumer Products Private Limited | | Wholly Owned Subsidiary Company | Sale of goods or services | | 600 | NA | 63.57 | 23.47 | 82.67 | | | | | | | | | | Textual Information(18) |
19 | Rossari Biotech Limited | | Tristar Intermediates Private Limited | | Wholly Owned Subsidiary Company | Sale of goods or services | | 150 | The Audit Committee has approved an aggregate limit of Rs.150 million | 14.79 | 6.34 | 5.65 | | | | | | | | | | Textual Information(19) |
20 | Rossari Biotech Limited | | Tristar Intermediates Private Limited | | Wholly Owned Subsidiary Company | Any other transaction | Commission Income | 150 | The Audit Committee has approved an aggregate limit of Rs.150 million | 5.06 | 0 | 0 | | | | | | | | | | Textual Information(20) |
21 | Rossari Biotech Limited | | Tristar Intermediates Private Limited | | Wholly Owned Subsidiary Company | Purchase of goods or services | | 2000 | NA | 716.93 | 277.41 | 297.66 | | | | | | | | | | Textual Information(21) |
22 | Rossari Biotech Limited | | Tristar Intermediates Private Limited | | Wholly Owned Subsidiary Company | Purchase of fixed assets | | 25 | NA | 0.42 | 0 | 0 | | | | | | | | | | Textual Information(22) |
23 | Rossari Biotech Limited | | Tristar Intermediates Private Limited | | Wholly Owned Subsidiary Company | Any other transaction | Employee Cost - Recovery | 50 | The Audit Committee has approved an aggregate limit of Rs.50 million | 16.13 | 0 | 0 | | | | | | | | | | Textual Information(23) |
24 | Rossari Biotech Limited | | Tristar Intermediates Private Limited | | Wholly Owned Subsidiary Company | Any other transaction | Recovery of Expenses | 50 | The Audit Committee has approved an aggregate limit of Rs.50 million | 3.28 | 0 | 0 | | | | | | | | | | Textual Information(24) |
25 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Sale of goods or services | | 3000 | The Audit Committee has approved an aggregate limit of Rs.3000 million | 385.86 | 36.81 | 56.5 | | | | | | | | | | Textual Information(25) |
26 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Any other transaction | Commission Income | 3000 | The Audit Committee has approved an aggregate limit of Rs.3000 million | 51.4 | 0 | 0 | | | | | | | | | | Textual Information(26) |
27 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Sale of fixed assets | | 50 | NA | 0.02 | 0 | 0 | | | | | | | | | | Textual Information(27) |
28 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Purchase of goods or services | | 4000 | NA | 1479.76 | 849.81 | 1174.15 | | | | | | | | | | Textual Information(28) |
29 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Purchase of fixed assets | | 50 | NA | 0.53 | 0 | 0 | | | | | | | | | | Textual Information(29) |
30 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Any other transaction | Employee Cost - Recovery | 120 | The Audit Committee has approved an aggregate limit of Rs.120 million | 60.24 | 0 | 0 | | | | | | | | | | Textual Information(30) |
31 | Rossari Biotech Limited | | Unitop Chemicals Private Limited | | Subsidiary Company | Any other transaction | Recovery of Expenses | 120 | The Audit Committee has approved an aggregate limit of Rs.120 million | 26.44 | 0 | 0 | | | | | | | | | | Textual Information(31) |
32 | Rossari Biotech Limited | | Romakk Chemicals Private Limited | | Fellow Subsidiary | Sale of goods or services | | 60 | NA | 5.68 | 0.69 | 0.66 | | | | | | | | | | Textual Information(32) |
33 | Rossari Biotech Limited | | Romakk Chemicals Private Limited | | Fellow Subsidiary | Purchase of goods or services | | 400 | NA | 85.76 | 43.05 | 35.03 | | | | | | | | | | Textual Information(33) |
34 | Rossari Biotech Limited | | Romakk Chemicals Private Limited | | Fellow Subsidiary | Any other transaction | Employee Cost - Recovery | 20 | The Audit Committee has approved an aggregate limit of Rs.20 million | 4.15 | 0 | 0 | | | | | | | | | | Textual Information(34) |
35 | Rossari Biotech Limited | | Romakk Chemicals Private Limited | | Fellow Subsidiary | Any other transaction | Recovery of Expenses | 20 | The Audit Committee has approved an aggregate limit of Rs.20 million | 0.42 | 0 | 0 | | | | | | | | | | Textual Information(35) |
36 | Rossari Biotech Limited | | K. K. Chempro (India) Private Limited | | Related Party to Romakk Chemicals Private
Limited (Subsidiary company) | Any other transaction | Receivables Ac | | NA | 0 | 0.01 | 0.01 | | | | | | | | | | Textual Information(36) |
37 | Rossari Biotech Limited | | K. K. Chempro (India) Private Limited | | Related Party to Romakk Chemicals Private
Limited (Subsidiary company) | Purchase of goods or services | | 90 | NA | 7.45 | 1.78 | 8.2 | | | | | | | | | | Textual Information(37) |
38 | Rossari Biotech Limited | | K K CHEMICAL INDUSTRIES | | Related Party to Romakk Chemicals Private
Limited (Subsidiary company) | Any other transaction | Payable Account Debit Balance | | NA | 0 | 0.05 | 0.05 | | | | | | | | | | Textual Information(38) |
39 | Rossari Biotech Limited | | McCoy Performance Silicones Private Limited | | Related Party to Romakk Chemicals Private
Limited (Subsidiary company) | Any other transaction | Payable Account Debit Balance | | NA | 0 | 0.01 | 0.01 | | | | | | | | | | Textual Information(39) |
40 | Unitop Chemicals Private Limited | | Gurudas Vishwas Aras | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.13 | 0 | 0 | | | | | | | | | | Textual Information(40) |
41 | Unitop Chemicals Private Limited | | Aparna Sharma | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.1 | 0 | 0 | | | | | | | | | | Textual Information(41) |
42 | Unitop Chemicals Private Limited | | Tristar Intermediates Private Limited | | Fellow Subsidiary | Sale of goods or services | | 250 | NA | 88.18 | 0 | 0 | | | | | | | | | | Textual Information(42) |
43 | Unitop Chemicals Private Limited | | Tristar Intermediates Private Limited | | Fellow Subsidiary | Purchase of goods or services | | 500 | NA | 125.75 | 41.8 | 32.28 | | | | | | | | | | Textual Information(43) |
44 | Unitop Chemicals Private Limited | | Tristar Intermediates Private Limited | | Fellow Subsidiary | Any other transaction | Purchase of Export Benefit License | 5 | NA | 1.24 | 0 | 0 | | | | | | | | | | Textual Information(44) |
45 | Unitop Chemicals Private Limited | | Buzil Rossari Private Limited | | Fellow Subsidiary | Any other transaction | Employee Cost - Reimbursement | 5 | NA | 0.89 | 0.57 | 0.44 | | | | | | | | | | Textual Information(45) |
46 | Unitop Chemicals Private Limited | | Hextar Unitop SDN.BHD. | | Joint Venture | Sale of goods or services | | 60 | NA | 4.23 | 2.46 | 0 | | | | | | | | | | Textual Information(46) |
47 | Unitop Chemicals Private Limited | | Romakk Chemicals Private Limited | | Fellow Subsidiary | Sale of goods or services | | 13 | NA | 1.92 | 0 | 0 | | | | | | | | | | Textual Information(47) |
48 | Unitop Chemicals Private Limited | | Romakk Chemicals Private Limited | | Fellow Subsidiary | Purchase of goods or services | | 150 | NA | 14.45 | 0 | 12.1 | | | | | | | | | | Textual Information(48) |
49 | Tristar Intermediates Private Limited | | Buzil Rossari Private Limited | | Fellow Subsidiary | Any other transaction | Employee Cost - Reimbursement | 5 | NA | 0.3 | 0.18 | 0.15 | | | | | | | | | | Textual Information(49) |
50 | Tristar Intermediates Private Limited | | Sanjay R Marballi | | Whole Time Director | Remuneration | | | NA | 5.6 | 0 | 0.63 | | | | | | | | | | Textual Information(50) |
51 | Tristar Intermediates Private Limited | | Krishna Kumar Tiwari | | Whole Time Director | Remuneration | | | NA | 2.26 | 0 | 0.28 | | | | | | | | | | Textual Information(51) |
52 | Tristar Intermediates Private Limited | | Krishna Kumar Tiwari | | Whole Time Director | Any other transaction | Employee Bonus Pool | | NA | 2 | 0 | 0 | | | | | | | | | | Textual Information(52) |
53 | Tristar Intermediates Private Limited | | Meher Castelino | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.08 | 0 | 0 | | | | | | | | | | Textual Information(53) |
54 | Tristar Intermediates Private Limited | | Gurudas Vishwas Aras | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.1 | 0 | 0 | | | | | | | | | | Textual Information(54) |
55 | Romakk Chemicals Private Limited | | Nitin Sethi | | Key Managerial Personnel | Remuneration | | | NA | 1.5 | 0 | 0 | | | | | | | | | | Textual Information(55) |
56 | Romakk Chemicals Private Limited | | Amit Malhotra | | Key Managerial Personnel | Remuneration | | | NA | 0.6 | 0 | 0 | | | | | | | | | | Textual Information(56) |
57 | Romakk Chemicals Private Limited | | Tristar Intermediates Private Limited | | Subsidiaries of enterprise exercising control over the Company | Purchase of goods or services | | 13 | NA | 8.08 | 0.39 | 6.46 | | | | | | | | | | Textual Information(57) |
58 | Romakk Chemicals Private Limited | | K. K. Chempro (India) Private Limited | | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Sale of goods or services | | 1 | NA | 0.13 | 0 | 0 | | | | | | | | | | Textual Information(58) |
59 | Romakk Chemicals Private Limited | | K. K. Chempro (India) Private Limited | | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Purchase of goods or services | | 50 | NA | 16.13 | 6.63 | 11.14 | | | | | | | | | | Textual Information(59) |
60 | Romakk Chemicals Private Limited | | K. K. Chempro (India) Private Limited | | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Rent | 1 | NA | 0.6 | 0.11 | 0.11 | | | | | | | | | | Textual Information(60) |
61 | Romakk Chemicals Private Limited | | K. K. Chempro (India) Private Limited | | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Others | 10 | NA | 0 | 1.45 | 0 | | | | | | | | | | Textual Information(61) |
62 | Romakk Chemicals Private Limited | | Nitin Sethi (HUF) | | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Rent | 1 | NA | 0.45 | 0.07 | 0.07 | | | | | | | | | | Textual Information(62) |
63 | Romakk Chemicals Private Limited | | Sumant Agrawal (HUF) | | Enterprises on which key managerial persons or their relatives are able to exercise significant influence | Any other transaction | Rent | 1 | NA | 0.45 | 0.1 | 0.08 | | | | | | | | | | Textual Information(63) |
64 | Romakk Chemicals Private Limited | | Gurudas Vishwas Aras | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.13 | 0 | 0 | | | | | | | | | | Textual Information(64) |
65 | Romakk Chemicals Private Limited | | Meher Castelino | | Independent Director | Any other transaction | Sitting Fees | | NA | 0.13 | 0 | 0 | | | | | | | | | | Textual Information(65) |
Total value of transaction during the reporting period | | | | | | | | | | 3385.53 | | | | | | | | | | | | |